|
|||||
|
|
Sugammadex is not associated with QT/QTc prolongation: methodology aspects of an intravenous moxifloxacin-controlled thorough QT study |
|
| Authors: | de Kam Pieter-Jan van Kuijk Jacqueline Smeets Jean Thomsen Torben Peeters Pierre |
| Affiliation: | Clinical Pharmacology, Merck Sharp & Dohme Corp., Whitehouse Station, NJ 07065-0900, USA. pieterjan.de.kam@merck.com |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |